Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
about
HIV-Host Interactions: Implications for Vaccine DesignCharacteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious DiseasesLatency reversal and viral clearance to cure HIV-1.Current views on the potential for development of a HIV vaccine.MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusCross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques.Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion.DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesInduction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.International AIDS Society global scientific strategy: towards an HIV cure 2016.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.New challenges in therapeutic vaccines against HIV infection.I've got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.Kill: boosting HIV-specific immune responses.The role of MHC class Ib-restricted T cells during infection.Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.Polyvalent vaccine approaches to combat HIV-1 diversityRecent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control.Unusual antigen presentation offers new insight into HIV vaccine design.Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination.Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Novel viral vectors in infectious diseases.Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.Graph-based optimization of epitope coverage for vaccine antigen design.
P2860
Q26765966-ED50A04A-4A25-4313-88B4-75EE55547132Q28079186-6AA5C213-0B97-48E2-B412-BD7ABEA9240CQ30248766-E92FFB51-EF69-413B-AF8B-F2B46BF4BF38Q30397595-BB67EE43-B370-4FD5-9B92-855F65B5D071Q33699588-4B078ABF-8A4D-4E7A-B1FB-E5FB641B6980Q33869332-3EB11DD4-6EFC-4C3C-9980-ADEAB3DC4042Q36106653-9C141BB0-C333-4F15-8A27-976C4F7DD67EQ36118554-85ECE46D-C7BD-4806-8AF2-0FC3D2437394Q36187466-BE829A03-6D41-4634-9B8A-67256C8BBAE6Q37221660-DC8D93B6-B605-46F4-B019-F9320BF8E74AQ37362291-BCE03474-C490-4E4E-B2BF-CBAEF5154651Q37395174-EFF52D46-29C5-4DB3-8260-03D442D4FACDQ37573037-D7649F61-2C17-461F-A5BC-BE81CD0D141DQ37621530-425CE043-2E01-4230-8EAB-E1924B390F26Q37628079-96896279-6442-4C78-98C4-A62D699E6C76Q37661770-1FE4F3E8-3073-4F8E-AA69-3F07E32784BBQ38433251-EA188F74-95EA-4BAD-9563-336BE9070575Q38692205-E45197F7-3770-42F5-9197-9D6913EB5172Q38731152-13A0DF40-5CB6-4EAB-B8AB-7A0D1EB74966Q38777005-F6102C34-0662-4D1F-B5A7-AA11069F87B2Q38786450-58500BA1-2ACE-45B1-8296-A63F42C52AC7Q38800533-7D10D631-11FB-4E3E-AD9C-D1520BED1719Q38883507-3026872A-6940-452A-B8BC-DC7873B4F239Q38985750-56F6F9F3-7770-4B1C-991D-8847A5572FBEQ39056737-D7FC63CA-52E8-4F0A-BEA0-6889FD4577E4Q39108740-478A7F48-9173-4EDB-BCEF-CF91707629EAQ39181144-F4284B2E-5F1F-4A19-B872-9C70B524318FQ39307257-E342F2B6-CC87-43FB-9340-55A3EF406E58Q39387367-C886430E-27D5-4B66-97E7-AE4ACF9DC388Q39451749-C3967C46-B76C-49AA-B7AA-B2D672C9822FQ40047250-2572F44F-07D2-4886-A442-BD471161997CQ40059020-3940D4D7-7039-47ED-8EF1-625D40EA8AFCQ40113278-1880C502-7A16-465A-8EDA-EB0D4664DF50Q40118193-C29A7EA0-D5BC-415F-A6A1-8F71A7BB61D9Q40147542-F24D03F6-7C1A-4123-9F94-377762786B5EQ40176792-B321A715-A471-4250-883A-7268CAD631F3Q40178622-81FB4AD0-5A1F-4701-BAC6-29D9D945B99AQ40201364-D289B834-2468-4C1E-81F7-31501E771575Q40298230-9BB9CCF4-1B29-4A5A-B6CD-C3E180DB257EQ40354550-8231400D-749B-4E20-959B-DEBDB1A5D40C
P2860
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@ast
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@en
type
label
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@ast
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@en
prefLabel
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@ast
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@en
P2093
P2860
P50
P356
P1433
P1476
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
@en
P2093
Abigail B Ventura
Alfred W Legasse
Andrea N Selseth
Andrew J McMichael
Benjamin J Burwitz
Colette M Hughes
César A López
Daniel Malouli
David W Morrow
Emily Ainslie
P2860
P304
P356
10.1126/SCIENCE.AAC9475
P407
P577
2016-01-21T00:00:00Z